Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • injection

    Tag: injection

    You Searched For "injection"
    Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected

    Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected

    Farhat Nasim6 Jan 2020 7:45 AM GMT
    New Delhi: In a major setback to Ranbaxy Laboratories Limited (now Sun Pharmaceutical Industries Ltd.), the Department of Pharmaceuticals (DoP) has...
    Indoco Remedies gets USFDA ANDA nod for Glycopyrrolate Injection

    Indoco Remedies gets USFDA ANDA nod for Glycopyrrolate Injection

    Medical Dialogues Bureau3 Nov 2019 4:30 AM GMT
    Glycopyrrolate is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the...
    Eli Lilly Vs Dr Reddys, Hospira: Court rules in favour of Lilly in Alimta alternate salt form patent lawsuit

    Eli Lilly Vs Dr Reddys, Hospira: Court rules in favour of Lilly in Alimta alternate salt form patent lawsuit

    Medical Dialogues Bureau13 Aug 2019 3:45 AM GMT
    The ruling came in the appeals of U.S. District Court decisions in the cases of Eli Lilly and Company v. Dr Reddy's Laboratories and Eli Lilly and...
    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    Farhat Nasim4 Jun 2019 12:14 PM GMT
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Shilpa Medicare gets USFDA nod for Irinotecan injection to treat cancer

    Shilpa Medicare gets USFDA nod for Irinotecan injection to treat cancer

    Farhat Nasim17 May 2019 8:15 AM GMT
    Irinotecan injection is used in the treatment of patients with metastatic carcinoma of the colon or rectum, the company added. NEW DELHI: Shilpa...
    Zydus Cadila gets final USFDA nod to generic version of Diamox for injection

    Zydus Cadila gets final USFDA nod to generic version of Diamox for injection

    Farhat Nasim18 April 2019 4:30 AM GMT
    Acetazolamide injection is a generic version of Diamox for injection.New Delhi: Drug firm Zydus Cadila Wednesday said it has received the final nod...
    NPPA revises ceiling price of 847 formulations including Metformin, Atrovastatin; Details

    NPPA revises ceiling price of 847 formulations including Metformin, Atrovastatin; Details

    Meghna A Singhania3 April 2019 12:38 PM GMT
    New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling prices of 847 formulations under the...
    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Meghna A Singhania17 March 2019 8:03 AM GMT
    New Delhi: In a major setback to Sun Pharmaceuticals Ltd, the drug price regulator the National Pharmaceutical Pricing Authority(NPPA) has refused to...
    Mylan launches generic Angiomax injection

    Mylan launches generic Angiomax injection

    Ruby Khatun Khatun22 Jun 2018 4:45 AM GMT
    HERTFORDSHIRE, England, and PITTSBURGH: Global pharmaceutical company Mylan N.V. announced the U.S. launch of Bivalirudin for Injection, 250 mg...
    Gene therapy for rare form of blindness wins US approval

    Gene therapy for rare form of blindness wins US approval

    Ruby Khatun Khatun21 Dec 2017 4:34 AM GMT
    WASHINGTON: U.S. health officials on Tuesday approved the nation's first gene therapy for an inherited disease, a treatment that improves the sight of...
    Lincoln Pharma gets patent for anti-malarial drug in India

    Lincoln Pharma gets patent for anti-malarial drug in India

    Ruby Khatun Khatun20 Dec 2017 6:32 AM GMT
    New Delhi: Lincoln Pharmaceuticals has been awarded a patent for an anti-malarial drug in India, the company said.The patent has been awarded by the...
    FDA approves Novo Nordisk diabetes drug Ozempic

    FDA approves Novo Nordisk diabetes drug Ozempic

    Ruby Khatun Khatun6 Dec 2017 5:00 AM GMT
    The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X